Cullinan Therapeutics, Inc. Common Stock vs. Twist Bioscience Corporation Common Stock
CGEM
Cullinan Therapeutics, Inc. Common Stock
$16.87 -22.15%
VS TWSTTwist Bioscience Corporation Common Stock
$158.50 -3.71%
Twist Bioscience Corporation Common Stock (TWST) comes out ahead, leading on 4 of 6 compared factors.
Size & Scale
| CGEM | TWST | |
|---|---|---|
| Market Cap | $1.39 billion | $10.91 billion |
| Revenue (TTM) | — | $431.80 million |
| Net Income (TTM) | $-204,688,000 | $-136,717,000 |
TWST leads on 3 of 3 size & scale factors.
Valuation
| CGEM | TWST | |
|---|---|---|
| Price / Book | 4.33 | 24.48 |
| Price / Sales | — | 25.27 |
CGEM leads on 1 of 1 valuation factors.
Profitability
| CGEM | TWST | |
|---|---|---|
| Net Margin | — | -31.66% |
| Return on Equity | -63.62% | -30.67% |
TWST leads on 1 of 1 profitability factors.
Risk & Sentiment
| CGEM | TWST | |
|---|---|---|
| Short Interest | 0.01% | 0.08% |
CGEM leads on 1 of 1 risk & sentiment factors.
Dig deeper: CGEM overview, CGEM financials, TWST overview, TWST financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.